India to Colombia: Carmustine Export Trade Route

The India to Colombia Carmustine corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $256.2K USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 59% of all export value, reflecting the consolidated nature of India's carmustine manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $36.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with carmustine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 27.0%, placing it at rank #4 among India's top carmustine export destinations globally.

On the import side, key buyers of Indian carmustine in Colombia include AL PHARMA S A S, AL PHARMA S.A.S, NEXT PHRMA SOURCING SAS and 2 others. AL PHARMA S A S is the single largest importer with 1 shipments valued at $99.8K USD.

India's carmustine exports to Colombia are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, SP ACCURE LABS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $36.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma : bicnu 100 mg injection (carmustine for injection 100 mg) - 1 vial (invoice no.: 2311300495 dt. 21.11.2023) and carm spal-p100(carmustinepowderfor concentratefor solution for infusionusp100mg/vial)b.no.24dcr01(anticancerdrugs-others, suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AL PHARMA S A S is the largest importer with 1 shipments worth $99.8K USD — representing 39% of all carmustine imports from India on this route.